香港股市 已收市

Advanced Medical Solutions Group plc (AQA.F)

Frankfurt - Frankfurt 延遲價格。貨幣為 EUR。
加入追蹤清單
2.3200+0.0400 (+1.75%)
市場開市。 截至 08:08AM CEST。

Advanced Medical Solutions Group plc

Premier Park
33 Road One Winsford Industrial Estate
Winsford CW7 3RT
United Kingdom
44 1606 863 500
https://www.admedsol.com

版塊Healthcare
行業Medical Instruments & Supplies
全職員工800

高階主管

名稱頭銜支付行使價出生年份
Mr. Andrew Christopher Meredith BSc (Hons)CEO & Executive Director836.98k1966
Mr. Edward Johnson ACACFO & Executive Director451.04k1972
Mr. Jonathan WhiteGroup Operations Director
截止 2022年12月31日為止計算的金額,現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 EUR。

描述

Advanced Medical Solutions Group plc, together with its subsidiaries, designs, develops, manufactures, and distributes products for the wound care, surgical, and wound closure markets in the United Kingdom, Germany, rest of Europe, the United States, and internationally. It operates in two segments, Surgical and Woundcare. The Surgical segment offers topical tissue adhesives for wound closure and sealing under the LiquiBand brand; sutures and collagen-based products for the surgical and dental markets under the RESORBA brand; collagens; and hernia mesh fixation device that allows for the accurate laparoscopic internal application of its cyanoacrylate adhesive to attach hernia meshes under the LiquiBandFix8 brand, as well as internal sealants under the Seal-G/Seal-G MIST brand. The Woundcare segment provides wound care platform technologies, which include alginates, foams, films, fibres, hydrogels, antimicrobials, and hydrocolloids, as well as wound care products under the ActivHeal brand, as well as under white-label. Advanced Medical Solutions Group plc was founded in 1991 and is headquartered in Winsford, the United Kingdom.

公司管治

截至 無 止,Advanced Medical Solutions Group plc 的 ISS 管治質素評分為 無。 Pillar 分數正在審核中:無;董事會:無;股東權利:無;現金賠償:無。

企業管治評分的資料提供: Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險,而 10 分表示較高的管治風險。